Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-02-03 @ 5:58 AM
Study NCT ID:
NCT02012959
Status:
TERMINATED
Last Update Posted:
2018-09-26
First Post:
2013-12-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hyponatremia | View |